Keywords
hydrops fetalis
Octreotide
Sildenafil
How to Cite
Abstract
Congenital chylothorax is rare with an incidence of 1:10,000-24,000 live births. Congenital chylothorax occurs in lymphatic disorders, heart diseases, cancers, chromosomal abnormalities, tracheoesophageal fistula, etc. Acquired causes are due to surgical thoracic duct trauma. Many cases of chylothorax are idiopathic. The case fatality rate is 15% to 57% and reaches 98% in hydrops foetalis. There is no set standard of treatment for congenital chylothorax. Prenatally, thoracentesis or pleuro-amniotic shunts are done. Postnatally, management of cause, drainage, dietary changes, Octreotide, and Sildenafil have variable results. Pleurodesis, pleuroperitoneal shunt, abrasion, thoracic duct ligation, and anastomoses are surgical options.
References
Rocha G, Arnet V, Soares P, Gomes Ac, Costa S, Guerra P, et al. Chylothorax in the neonate - A stepwise approach algorithm. Paediatr Pulmonol. 2021;56(10):3093-105. [PubMed | Full Text | DOI]
Au M, Weber TR, Fleming RE. Successful use of somatostatin in a case of neonatal chylothorax. J Pediatr Surg. 2003;38(7):1106-7. [PubMed | Full Text | DOI]
Al-Tawil K, Ahmed G, Al-Hathal M, Al-Jarallah Y, Campbell N. Congenital chylothorax. Am J Perinatol. 2000;17(3):121-6. [PubMed | Full Text | DOI]
Brissaud O, Desfrere L, Mohsen R, Fayon M, Demarquez J. Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed. 2003;88(6):F531-3. [PubMed | Full Text | DOI]
Höck M, Höller A, Hammerl M, Wechselberger K, Krossslhuber J, Kiechl-Kohlendorfer U, et al. Dietary treatment of congenital chylothorax with skimmed breast milk. Ital J Paediatr. 2021;47(1):175. [PubMed | Full Text | DOI]
Das A, Shah PS. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev. 2010;(9):CD006388. [PubMed | Full Text | DOI]
Büttiker V, Fanconi S, Burger R. Chylothorax in children: guidelines for diagnosis and management. Chest. 1999;116(3):682-7. [PubMed | Full Text | DOI]
Krishnamurthy MB, Malhotra A. Congenital chylothorax: Current perspectives and trends. Research and Reports in Neonatology. 2017;7:53-63. [Full Text | DOI]
Attar MA, Donn SM. Congenital chylothorax. Semin Fetal Neonatal Med. 2017;22(4):234-9. [PubMed | Full Text | DOI]
Selle JG, Snyder WH, Schreiber JT. Chylothorax: indications for surgery. Ann Surg. 1973;177(2):245-249. doi:10.1097/00000658-197302000-00022 [PubMed | Full Text | DOI]
Bartha JL, Comino-Delgado R. Fetal chylothorax response to maternal dietary treatment. Obstet Gynecol. 2001;97(5 Pt 2):820-3. [PubMed | Full Text | DOI]
Malla T, Sathian B, Karmacharya Malla K, Adhikari S. Urinary tract infection in asymptomatic newborns with prolonged unconjugated hyperbilirubunemia: A hospital based observational study from western region of nepal. Kathmandu Univ Med J (KUMJ). 2016;14(53):41-6. [PubMed | Full Text]
Okawa T, Takano Y, Fujimori K, Yanagida K, Sato A. A new fetal therapy for chylothorax: Pleurodesis with OK-432. Ultrasound Obstet Gynecol. 2001;18(4):376-7. [PubMed | Full Text | DOI]
Peitersen B, Jacobsen B. Medium chain triglycerides for treatment of spontaneous, neonatal chylothorax. Lipid analysis of the chyle. Acta Paediatr Scand. 1977;66(1):121-5. [PubMed | Full Text | DOI]
Kocel SL, Russell J, O’Connor DL. Fat-modified breast milk resolves chylous pleural effusion in infants with postsurgical chylothorax but is associated with slow growth. J Parenter Enteral Nutr. 2016;40(4):543-51. [PubMed | Full Text | DOI]
Chan GM, Lechtenberg E. The use of fat-free human milk in infants with chylous pleural effusion. J Perinatol. 2007;27(7):434-6. [PubMed | Full Text | DOI]
Bulbul A, Unsur EK. Octreotid as a treatment of congenital chylothorax. Paediatr Pulmonol. 2010;45(6):628-628. [PubMed | Full Text | DOI]
Siu SLY, Lam DSY. Spontaneous neonatal chylothorax treated with octreotide. J Paediatr Child Health. 2006;42(1-2):65-7. [PubMed | Full Text | DOI]
Vass G, Fry RE, Roehr CC. Should newborns with refractory chylothorax be tried on higher dose of octreotide? Neonatology. 2021;118(1):122-6. doi:10.1159/000512461 [PubMed | Full Text | DOI]
Leelahanon S, Petlek W, Sontimuang W, Pochanart P, Tepakorn V, Ruangpeg S. Can octreotide be the first line treatment for chylothorax? J Med Assoc Thai. 2003;86 Suppl 3:S741-5. [PubMed | Full Text]
Bellini C, Cabano R, De Angelis LC, Bellini T, Calevo MG, Gandullia P, et al. Octreotide for congenital and acquired chylothorax in newborns: A systematic review. J Paediatr Child Health. 2018;54(8):840-7. [PubMed | Full Text | DOI]
Roehr CC, Jung A, Proquitté H, Blankenstein O, Hammer H, Lakhoo K, et al. Somatostatin or octreotide as treatment options for chylothorax in young children: A systematic review. Intensive Care Med. 2006;32(5):650-7. [PubMed | Full Text | DOI]
Danial C, Tichy AL, Tariq U, Swetman GL, Khuu P, Leung TH, et al. An open-label study to evaluate sildenafil for the treatment of lymphatic malformations. J Am Acad Dermatol. 2014;70(6):1050-7. [PubMed | Full Text | DOI]
Swetman GL, Berk DR, Vasanawala SS, Feinstein JA, Lane AT, Bruckner AL. Sildenafil for severe lymphatic malformations. N Engl J Med. 2012;366(4):384-6. [PubMed | Full Text | DOI]
Malleske DT, Yoder BA. Congenital chylothorax treated with oral sildenafil: A case report and review of the literature. J Perinatol. 2015;35(5):384-6. doi:10.1038/jp.2015.10 [PubMed | Full Text | DOI]
Beghetti M, La Scala G, Belli D, Bugmann P, Kalangos A, Le Coultre C. Etiology and management of pediatric chylothorax. J Pediatr. 2000;136(5):653-8. [PubMed | Full Text | DOI]
Akcakus M, Koklu E, Bilgin M, Kurtoglu S, Altunay L, Canpolat M, et al. Congenital pulmonary lymphangiectasia in a newborn: A response to autologous blood therapy. Neonatology. 2007;91(4):256-9. [PubMed | Full Text | DOI]
Matsukuma E, Aoki Y, Sakai M, Kawamoto N, Watanabe H, Iwagaki S, et al. Treatment with ok-432 for persistent congenital chylothorax in newborn infants resistant to octreotide. J Paediatr Surg. 2009;44(3):e37-9. [PubMed | Full text | DOI]
Utture A, Kodur V, Mondkar J. Chemical pleurodesis with oxytetracycline in congenital chylothorax. Indian Paediatr. 2016;53(12):1105-6. [PubMed | Full Text]
Itkin M, Krishnamurthy G, Naim MY, Bird GL, Keller MS. Percutaneous thoracic duct embolisation as a treatment for intrathoracic chyle leaks in infants. Paediatrics. 2011;128(1):e237-41. [PubMed | Full Text | DOI]